Difference between revisions of "IL21R-AS1"
| Line 7: | Line 7: | ||
===RefSeq ID=== | ===RefSeq ID=== | ||
NR_037158 | NR_037158 | ||
| − | |||
| − | |||
===Expression=== | ===Expression=== | ||
qPCR analysis shows that IL21R-AS1 is 2.212-fold up-regulated in CAD (coronary artery disease) patients.<ref name="ref1" /> | qPCR analysis shows that IL21R-AS1 is 2.212-fold up-regulated in CAD (coronary artery disease) patients.<ref name="ref1" /> | ||
| − | |||
===Disease=== | ===Disease=== | ||
coronary artery disease. <ref name="ref1" /> | coronary artery disease. <ref name="ref1" /> | ||
| − | |||
==Labs working on this lncRNA== | ==Labs working on this lncRNA== | ||
* Department of Cardiology, Daping Hospital, The Third Military Medical University, Chongqing, P.R. China. | * Department of Cardiology, Daping Hospital, The Third Military Medical University, Chongqing, P.R. China. | ||
Revision as of 07:57, 15 October 2017
Contents
Annotated Information
Approved Symbol
IL21R-AS1 (IL21R antisense RNA 1)
Chromosome
16p12.1
RefSeq ID
NR_037158
Expression
qPCR analysis shows that IL21R-AS1 is 2.212-fold up-regulated in CAD (coronary artery disease) patients.[1]
Disease
coronary artery disease. [1]
Labs working on this lncRNA
- Department of Cardiology, Daping Hospital, The Third Military Medical University, Chongqing, P.R. China.
- Chongqing Institute of Cardiology, Chongqing, P.R. China.
